Potensi Interaksi Senyawa Fenolik Ocimum basilicum dengan Reseptor 5-HT2A: Kajian Molecular Docking dan Prediksi ADME–Toksisitas
Downloads
Depresi mayor merupakan masalah kesehatan yang penting, sedangkan reseptor serotonin 5-HT2A menjadi sasaran penelitian dengan farmakologi yang kompleks. Penelitian ini menelaah kembali hasil komputasional tiga senyawa fenolik yang dikaji terkait Ocimum basilicum, yaitu apigenin-7-O-glukuronida, dihidrokaempferol-3-glukosida, dan aeskuletin, terhadap reseptor 5-HT2A manusia (PDB: 6A93). Data asli berasal dari penambatan molekuler AutoDock Vina dan prediksi absorpsi, distribusi, metabolisme, ekskresi, serta toksisitas (ADMET). Penyusunan ulang ini menggunakan hasil numerik yang dilaporkan tanpa mengklaim pengujian komputasi baru. Nilai afinitas penambatan masing-masing adalah ?8,5; ?7,2; dan ?6,5 kkal/mol, sedangkan vilazodon dan vortioksetin berturut-turut ?5,7 dan ?5,6 kkal/mol. Prediksi absorpsi intestinal adalah 15,25%; 36,32%; dan 86,29%, dengan indeks sawar darah–otak sebesar ?1,305; ?1,260; dan 0,025 log BB. Pemeriksaan basis data independen menemukan ketidaksesuaian pada beberapa deskriptor molekul dalam tabel awal. Skor penambatan menunjukkan prioritas eksplorasi, bukan bukti antagonisme atau efektivitas antidepresan. Validasi identitas ligan, penambatan ulang, uji fungsi reseptor, serta pengukuran paparan di otak diperlukan sebelum senyawa diusulkan sebagai kandidat terapeutik.
Al Azzam, K. (2023). SwissADME and pkCSM webservers predictors: An integrated online platform for accurate and comprehensive predictions for in silico ADME/T properties of artemisinin and its derivatives. Complex Use of Mineral Resources, 325(2), 14–21. https://doi.org/10.31643/2023/6445.13
Alizadeh, A., Pourfallah-Taft, Y., Khoshnazar, M., Safdari, A., Komari, S. V., Zanganeh, M., Sami, N., Valizadeh, M., Faridzadeh, A., Alijanzadeh, D., Mazhari, S. A., Khademi, R., Kheirandish, A., & Naziri, M. (2024). Flavonoids against depression: A comprehensive review of literature. Frontiers in Pharmacology, 15, 1411168. https://doi.org/10.3389/fphar.2024.1411168
Arias, H. R., Rudin, D., Luethi, D., Valenta, J., Lesniak, A., Czartoryska, Z., Olejarz-Maciej, A., Doroz-Plonka, A., Manetti, D., De Deurwaerdere, P., Romanelli, M. N., Handzlik, J., Liechti, M. E., & Chagraoui, A. (2024). The psychoplastogens ibogaminalog and ibogainalog induce antidepressant-like activity in naive and depressed mice by mechanisms involving 5-HT2A receptor activation and serotonergic transmission. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 111217. https://doi.org/10.1016/j.pnpbp.2024.111217
Banerjee, P., Kemmler, E., Dunkel, M., & Preissner, R. (2024). ProTox 3.0: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Research, 52(W1), W513–W520. https://doi.org/10.1093/nar/gkae303
Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., Martell, J., Blemings, A., Erritzoe, D., & Nutt, D. J. (2021). Trial of psilocybin versus escitalopram for depression. The New England Journal of Medicine, 384(15), 1402–1411. https://doi.org/10.1056/NEJMoa2032994
Casey, A. B., Cui, M., Booth, R. G., & Canal, C. E. (2022). “Selective” serotonin 5-HT2A receptor antagonists. Biochemical Pharmacology, 200, 115028. https://doi.org/10.1016/j.bcp.2022.115028
Che, X., Liu, Q., & Zhang, L. (2023). An accurate and universal protein-small molecule batch docking solution using AutoDock Vina. Results in Engineering, 19, 101335. https://doi.org/10.1016/j.rineng.2023.101335
Chen, L., Cao, H., Huang, Q., Xiao, J., & Teng, H. (2022). Absorption, metabolism and bioavailability of flavonoids: A review. Critical Reviews in Food Science and Nutrition, 62(28), 7730–7742. https://doi.org/10.1080/10408398.2021.1917508
Chen, Y., Peng, F., Xing, Z., Chen, J., Peng, C., & Li, D. (2022). Beneficial effects of natural flavonoids on neuroinflammation. Frontiers in Immunology, 13, 1006434. https://doi.org/10.3389/fimmu.2022.1006434
Danis, A., Kilinc, Y. B., Torun, I. E., Hanci, F., Kilinc, E., & Ankarali, H. (2023). Esculetin alleviates pentylenetetrazole-induced seizures, cognitive impairment and pro-inflammatory cytokines and suppresses penicillin-induced epileptiform activity in rats. Life Sciences, 313, 121300. https://doi.org/10.1016/j.lfs.2022.121300
Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2021). Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial. JAMA Psychiatry, 78(5), 481–489. https://doi.org/10.1001/jamapsychiatry.2020.3285
Du, B.-X., Xu, Y., Yiu, S.-M., & Yu, H. (2023). ADMET property prediction via multi-task graph learning under adaptive auxiliary task selection. iScience, 26(11), 108285. https://doi.org/10.1016/j.isci.2023.108285
Duan, W., Cao, D., Wang, S., & Cheng, J. (2024). Serotonin 2A receptor (5-HT2AR) agonists: Psychedelics and non-hallucinogenic analogues as emerging antidepressants. Chemical Reviews, 124(1), 124–163. https://doi.org/10.1021/acs.chemrev.3c00375
Dulsat, J., Lopez-Nieto, B., Estrada-Tejedor, R., & Borrell, J. I. (2023). Evaluation of free online ADMET tools for academic or small biotech environments. Molecules, 28(2), 776. https://doi.org/10.3390/molecules28020776
Eberhardt, J., Santos-Martins, D., Tillack, A. F., & Forli, S. (2021). AutoDock Vina 1.2.0: New docking methods, expanded force field, and Python bindings. Journal of Chemical Information and Modeling, 61(8), 3891–3898. https://doi.org/10.1021/acs.jcim.1c00203
Fu, L., Shi, S., Yi, J., Wang, N., et al. (2024). ADMETlab 3.0: An updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Research, 52(W1), W422–W431. https://doi.org/10.1093/nar/gkae236
Goodwin, G. M., Aaronson, S. T., Alvarez, O., Arden, P. C., Baker, A., Bennett, J. C., Bird, C., et al. (2022). Single-dose psilocybin for a treatment-resistant episode of major depression. The New England Journal of Medicine, 387, 1637–1648. https://doi.org/10.1056/NEJMoa2206443
Hamid, S., Oukil, N. F., Moussa, H., Djihad, N., Mroz, M., Kusznierewicz, B., Attia, A., Djenadi, K., Mahdjoub, M. M., Bouhenna, M. M., et al. (2024). Chemical and biological characterization of Ocimum basilicum L. phenolic extract and essential oil derived through ultrasound and microwave-assisted extraction techniques. Food Bioscience, 60, 104359. https://doi.org/10.1016/j.fbio.2024.104359
Husain, M. I., Ledwos, N., Fellows, E., Baer, J., Rosenblat, J. D., Blumberger, D. M., Mulsant, B. H., & Castle, D. J. (2023). Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?. Frontiers in Psychiatry, 13, 1076459. https://doi.org/10.3389/fpsyt.2022.1076459
Jakovljevic, D., Kruszka, D., Waligórski, P., Warcho?, M., & Skrzypek, E. (2024). Untargeted metabolomic in basil cell cultures—A case study of Ocimum basilicum L. var. minimum Alef.. Physiologia Plantarum, 176(1), e14203. https://doi.org/10.1111/ppl.14203
Jazvinscak Jembrek, M., Orsolic, N., Karlovic, D., & Peitl, V. (2023). Flavonols in action: Targeting oxidative stress and neuroinflammation in major depressive disorder. International Journal of Molecular Sciences, 24(8), 6888. https://doi.org/10.3390/ijms24086888
Kabra, A., Garg, R., Brimson, J., Zivkovic, J., Almawash, S., Ayaz, M., Nawaz, A., Hassan, S. S. U., & Bungau, S. (2022). Mechanistic insights into the role of plant polyphenols and their nano-formulations in the management of depression. Frontiers in Pharmacology, 13, 1046599. https://doi.org/10.3389/fphar.2022.1046599
Kargbo, R. B. (2024). Neuropharmacological advances: Harnessing 5-HT2A receptor modulators and psychoplastogens. ACS Medicinal Chemistry Letters, 15(2), 171–173. https://doi.org/10.1021/acsmedchemlett.4c00003
Kim, K., Che, T., Panova, O., DiBerto, J. F., Lyu, J., Krumm, B. E., Wacker, D., Robertson, M. J., Seven, A. B., Nichols, D. E., Shoichet, B. K., Skiniotis, G., & Roth, B. L. (2020). Structure of a hallucinogen-activated Gq-coupled 5-HT2A serotonin receptor. Cell, 182(6), 1574–1588.e19. https://doi.org/10.1016/j.cell.2020.08.024
Mahmoud, E., Starowicz, M., Ciska, E., Topolska, J., & Farouk, A. (2022). Determination of volatiles, antioxidant activity, and polyphenol content in the postharvest waste of Ocimum basilicum L.. Food Chemistry, 375, 131692. https://doi.org/10.1016/j.foodchem.2021.131692
Nadeem, H. R., Akhtar, S., Sestili, P., et al. (2022). Toxicity, antioxidant activity, and phytochemicals of basil (Ocimum basilicum L.) leaves cultivated in Southern Punjab, Pakistan. Foods, 11(9), 1239. https://doi.org/10.3390/foods11091239
Naeem, A., Ming, Y., Pengyi, H., Jie, K. Y., Yali, L., Haiyan, Z., Shuai, X., Wenjing, L., Ling, W., Xia, Z. M., Shan, L. S., & Qin, Z. (2022). The fate of flavonoids after oral administration: A comprehensive overview of its bioavailability. Critical Reviews in Food Science and Nutrition, 62(22), 6169–6186. https://doi.org/10.1080/10408398.2021.1898333
Qamar, F., Sana, A., Naveed, S., & Faizi, S. (2023). Phytochemical characterization, antioxidant activity and antihypertensive evaluation of Ocimum basilicum L. in L-NAME induced hypertensive rats and its correlation analysis. Heliyon, 9(4), e14644. https://doi.org/10.1016/j.heliyon.2023.e14644
Raison, C. L., Sanacora, G., Woolley, J., Heinzerling, K., Dunlop, B. W., Brown, R. T., Kakar, R., Hassman, M., Trivedi, R. P., Robison, R., Gukasyan, N., Nayak, S. M., Hu, X., O’Donnell, K. C., Kelmendi, B., Sloshower, J., Penn, A. D., Bradley, E., Kelly, D. F., et al. (2023). Single-dose psilocybin treatment for major depressive disorder: A randomized clinical trial. JAMA, 330(9), 843–853. https://doi.org/10.1001/jama.2023.14530
Ryu, D. H., Cho, J. Y., Hamayun, M., Lee, D. G., & Kim, H.-Y. (2024). Metabolic modulation of basil (Ocimum basilicum L.): An insight into growth, metabolomics and antioxidant activity under varying temperature and light conditions. Chemical and Biological Technologies in Agriculture, 11, 10. https://doi.org/10.1186/s40538-023-00532-2
Sarkar, A., Concilio, S., Sessa, L., Marrafino, F., & Piotto, S. (2024). Advancements and novel approaches in modified AutoDock Vina algorithms for enhanced molecular docking. Results in Chemistry, 7, 101319. https://doi.org/10.1016/j.rechem.2024.101319
Sforzini, L., Worrell, C., Kose, M., Anderson, I. M., Aouizerate, B., Arolt, V., Bauer, M., Baune, B. T., Blier, P., Cleare, A. J., Cowen, P. J., Dinan, T. G., Fagiolini, A., et al. (2022). A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials. Molecular Psychiatry, 27, 1286–1299. https://doi.org/10.1038/s41380-021-01381-x
Teofilovic, B., Grujic-Letic, N., Karadzic, M., Kovaecvic, S., Podunavac-Kuzmanovic, S., Gligoric, E., & Gadzuric, S. (2021). Analysis of functional ingredients and composition of Ocimum basilicum. South African Journal of Botany, 141, 227–234. https://doi.org/10.1016/j.sajb.2021.04.035
Vahid-Ansari, F., & Albert, P. R. (2021). Rewiring of the serotonin system in major depression. Frontiers in Psychiatry, 12, 802581. https://doi.org/10.3389/fpsyt.2021.802581
Vargas, M. V., Dunlap, L. E., Dong, C., Carter, S. J., Tombari, R. J., Jami, S. A., Cameron, L. P., Patel, S. D., Hennessey, J. J., Saeger, H. N., McCorvy, J. D., Gray, J. A., Tian, L., & Olson, D. E. (2023). Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors. Science, 379(6633), 700–706. https://doi.org/10.1126/science.adf0435
Vas, C., Jain, A., Trivedi, M., Jha, M. K., & Mathew, S. J. (2023). Pharmacotherapy for treatment-resistant depression: Antidepressants and atypical antipsychotics. Psychiatric Clinics of North America, 46(2), 261–275. https://doi.org/10.1016/j.psc.2023.02.012
Venkataraman, M., Rao, G. C., Madavareddi, J. K., & Maddi, S. R. (2026). Leveraging machine learning models in evaluating ADMET properties for drug discovery and development. ADMET and DMPK. https://doi.org/10.5599/admet.2772
von Rotz, R., Schindowski, E. M., Jungwirth, J., Schuldt, A., Rieser, N. M., Zahoranszky, K., Seifritz, E., Nowak, A., Nowak, P., Jäncke, L., Preller, K. H., & Vollenweider, F. X. (2023). Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial. eClinicalMedicine, 56, 101809. https://doi.org/10.1016/j.eclinm.2022.101809
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023). The blood–brain barrier: Structure, regulation and drug delivery. Signal Transduction and Targeted Therapy, 8, 217. https://doi.org/10.1038/s41392-023-01481-w
Yan, G., Zhang, Y., Wang, S., Yan, Y., Liu, M., Tian, M., & Tian, W. (2024). Global, regional, and national temporal trend in burden of major depressive disorder from 1990 to 2019: An analysis of the global burden of disease study. Psychiatry Research, 337, 115958. https://doi.org/10.1016/j.psychres.2024.115958
Yao, X., Yu, M., Zhou, Y., & Guan, H. (2022). Esculetin ameliorates cognitive impairments in D-galactose-induced Alzheimer’s disease rats by inhibiting inflammation and oxidative stress. Pharmacognosy Magazine, 18(79), 540–547. https://doi.org/10.4103/pm.pm_524_21
Zayed, A., Farag, M. A., Mehring, A., Salem, M. A., Ibrahim, R. M., Alseekh, S., Fernie, A. R., & Ulber, R. (2023). Methyl jasmonate elicitation effect on the metabolic profile of cambial meristematic cells culture derived from sweet basil (Ocimum basilicum L.) in relation to antioxidant activity: Untargeted metabolomics study in a time-based approach. Phytochemistry, 213, 113777. https://doi.org/10.1016/j.phytochem.2023.113777
Zieba, A., St?pnicki, P., Matosiuk, D., & Kaczor, A. A. (2022). Overcoming depression with 5-HT2A receptor ligands. International Journal of Molecular Sciences, 23(1), 10. https://doi.org/10.3390/ijms23010010
Copyright (c) 2026 Harsoeni Harsoeni, Hanief Al Hadi

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.





